Jesse M. Cedarbaum

Affiliations: 
Elan Pharmacueticals, Inc, South San Francisco, CA, United States 
Area:
Neruodegenerative disorders, clinical trials
Google:
"Jesse Cedarbaum"
Mean distance: 15.61 (cluster 6)
 
SNBCP
Cross-listing: Chemistry Tree

BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Cedarbaum JM, Aghajanian GK. (1978) Afferent projections to the rat locus coeruleus as determined by a retrograde tracing technique. The Journal of Comparative Neurology. 178: 1-16
Cedarbaum JM, Aghajanian GK. (1978) Activation of locus coeruleus neurons by peripheral stimuli: modulation by a collateral inhibitory mechanism. Life Sciences. 23: 1383-92
Aghajanian GK, Cedarbaum JM, Wang RY. (1977) Evidence for norepinephrine-mediated collateral inhibition of locus coeruleus neurons. Brain Research. 136: 570-7
Davis M, Cedarbaum JM, Aghajanian GK, et al. (1977) Effects of clonidine on habituation and sensitization of acoustic startle in normal, decerebrate and locus coeruleus lesioned rats. Psychopharmacology. 51: 243-53
Cedarbaum JM, Aghajanian GK. (1977) Catecholamine receptors on locus coeruleus neurons: pharmacological characterization. European Journal of Pharmacology. 44: 375-85
Cedarbaum JM, Aghajanian GK. (1976) Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the alpha-antagonist piperoxane. Brain Research. 112: 413-9
Garver DL, Cedarbaum J, Maas JW. (1975) Blood-brain barrier to 6-hydroxydopamine: Uptake by heart and brain Life Sciences. 17: 1081-1084
See more...